ICON plc, a clinical research organization, expanded its portfolio of artificial intelligence (AI) tools that aim to deliver efficiencies across the clinical trial process, including study startup, ...

In a report released today, Matt Hewitt from Craig-Hallum maintained a Buy rating on Schrodinger (SDGR – Research Report). The company’s shares ...

When you think about the transformation of the United States over the past two centuries, it looks like a completely ...

RBC Capital analyst Matthew Hedberg raised the firm’s price target on Dynatrace (DT) to $69 from $65 and keeps an Outperform rating on the ...